KC
TCBP

KCL Capital’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

KCL Capital’s Portfolio TCBP Stock Details TCBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed -$37K – 45
2022
Q2 		$37K Buy
+1
New +$148K 0.01% 29

Other funds holding TCBP

Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
MFGM
Marshall Financial Group (Maryland) Hunt Valley, Maryland $625M AUM 21.18% 1-Year Est. Return

KCL Capital's TCBP Position: Q3 2022 in Review

KCL Capital sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q3 2022, closing a stake of 1 share — an estimated $37K sold.

KCL Capital first reported a position in TCBP in Q2 2022 and held it in 1 quarter. The position peaked at $37K in Q2 2022. 3 funds tracked by Wall St. Rank hold TCBP as of Q3 2022.

  • KCL Capital reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • KCL Capital sold 1 TC BioPharm (Holdings) plc American Depositary Shares share in Q3 2022, an estimated $37K.
  • KCL Capital first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q2 2022 and held it in 1 quarter.
  • KCL Capital's TC BioPharm (Holdings) plc American Depositary Shares position peaked at $37K in Q2 2022.
  • 3 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q3 2022.

Based on KCL Capital's 13F filing for Q3 2022, filed 14 Nov 2022.